Home » Topics » Immuno-oncology, BioWorld Science

Immuno-oncology, BioWorld Science
RSS

KRN-7000 for the treatment of liver metastasis

Oct. 23, 1997

Imutec's Virulizin approved in Mexico for malignant melanoma

Oct. 23, 1997

Update on development of NeoPharm's novel chimeric human protein

Oct. 21, 1997

Bexxar compared to unlabeled MAb in patients with non-Hodgkin's lymphoma

Oct. 21, 1997

Avax evaluates its ovarian cancer vaccine in phase II

Oct. 20, 1997

New GVAX cancer vaccine begins human testing

Oct. 17, 1997

Jenner Technologies initiates clinical testing of AdjuVax-100a

Oct. 16, 1997

Meeting of Biological Response Modifiers Advisory Committee this week

Oct. 14, 1997

Cancer cells being used to treat cancer

Oct. 13, 1997

Phase II results for IDEC-C2B8 in NHL

Oct. 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 7, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 7, 2024.
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...
Sanofi bets on Resalis’ oligonucleotide RES-010 for obesity
BioWorld
After missing out on the glucagon-like peptide 1 obesity market, Sanofi SA is prospecting for next-generation drugs and is making a strategic equity investment in...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.